Epidermal growth factor dressing in comparison to Collagen sheet dressing for Skin graft donor site wound

After the clearance from the IRC and IEC, sampling of patients for Epidermal Growth Factor and Collagen sheet dressing done by Group Allocation concealment method during the study period mentioned, fulfilling the inclusion and exclusion criteria already listed above will be recruited for the study, after obtaining informed consent. The nature, purpose, and the roles in the study will be explained in detailed, including the information that their non-participation in the study would not affect the quality of the treatment that they are to receive and that they are free exit the study at any time. After assuring that their response would remain confidential, an informed written consent for the same shall be obtained from the all participants.

Patients will be randomized into two groups. This is done by Group Allocation Concealment Method (i.e) Patient has been separated randomly into two groups by single blinding technique as the investigator alone knows which patient is in which group.

Collagen sheet dressing and Epidermal Growth Factor dressing will be performed for both the groups. In one group Collagen sheet dressing and in the other group Epidermal Growth Factor dressing will be performed. Duration of wound healing, post operative complications has been evaluated. Donor site dressing will be opened only after 14 days of surgery. On Post operative day 2, 4 and 6 , I will measure pain of the patients using Pain score scale. On Post operative day 14, 1 st look of the donor site wound will be done and 2 nd look will be done on post op day 21 based on scar pigmentation (Normal /Hypopigmentation /Hyperpigmentation), scab formation, infection.